Home Newsfeeds Maxim Group Maintains Buy on BWX Technologies, Raises Price Target to $70

Maxim Group Maintains Buy on BWX Technologies, Raises Price Target to $70

Maxim Group analyst Tate Sullivan maintains BWX Technologies (NYSE:BWXT) with a Buy and raises the price target from $65 to $70.

November 29, 2022

1 minute read

Maxim Group analyst Tate Sullivan maintains BWX Technologies (NYSE:BWXT) with a Buy and raises the price target from $65 to $70.

Hims & Hers Health’s Model ‘Proving Effective’: 2 Analysts Examine Q1 Earnings

May 7, 12:57 PM

Hims & Hers Health reported total revenue of $278.2 million, a 46% year-on-year growth and higher than Street expectations of $270.4 million.

January 5, 9:33 AM

Walgreens Boots Alliance Inc (NASDAQ:WBA) is reportedly the first major national pharmacy chain to say it plans to dispense…

March 16, 8:46 AM

JP Morgan analyst Eric Joseph maintains Atea Pharmaceuticals (NASDAQ:AVIR) with a Neutral and lowers the price target from $12 to $8.

January 24, 1:57 PM

RBC Capital Markets analyst Nik Modi reiterated a Sector Perform rating on the shares of Kimberly-Clark Corporation (NYSE:KMB) with a price target…